comparemela.com

Latest Breaking News On - Cipher pharmaceuticals price performance - Page 1 : comparemela.com

Cipher Pharmaceuticals (TSE:CPH) Cut to Hold at Stifel Nicolaus

Cipher Pharmaceuticals (TSE:CPH) Cut to Hold at Stifel Nicolaus
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Cipher Pharmaceuticals (TSE:CPH) Sets New 52-Week High at $7 81

Cipher Pharmaceuticals Inc. (TSE:CPH – Get Free Report) (NASDAQ:CPHR)’s share price reached a new 52-week high during trading on Tuesday . The company traded as high as C$7.81 and last traded at C$7.73, with a volume of 44782 shares. The stock had previously closed at C$7.24. Analyst Ratings Changes Separately, Citigroup upped their price objective […]

Cipher Pharmaceuticals (TSE:CPH) Reaches New 1-Year High on Analyst Upgrade

Cipher Pharmaceuticals (TSE:CPH) Reaches New 1-Year High on Analyst Upgrade
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Cipher Pharmaceuticals (TSE:CPH) Stock Passes Above Fifty Day Moving Average of $5 97

Cipher Pharmaceuticals (TSE:CPH) Stock Passes Above Fifty Day Moving Average of $5 97
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Cipher Pharmaceuticals Inc (OTCMKTS:CPHRF) Sees Significant Increase in Short Interest

Cipher Pharmaceuticals Inc. (OTCMKTS:CPHRF – Get Free Report) (TSE:CPH) was the target of a significant increase in short interest during the month of October. As of October 31st, there was short interest totalling 5,500 shares, an increase of 223.5% from the October 15th total of 1,700 shares. Based on an average daily volume of 7,300 […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.